Psicotric Prolong 300 mg prolonged-release tablets EFG
SpainTable of Contents
- Package leaflet: Information for the user
- Introduction
- 1. What Psicotric Prolong is and what it is used for
- 2. What you need to know before starting to take Psicotric Prolong
- Do not take Psicotric Prolong:
- 3. How to take Psicotric Prolong
- Follow exactly the administration instructions for this medicine as indicated by your doctor. If in doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your condition and individual needs but will usually be between 150 mg and 800 mg.
- 4. Possible adverse effects
- 5. Conservation of Psicotric Prolong
- Keep this medicine out of the sight and reach of children.
- 6. Contents of the pack and other information
- Composition of Psicotric Prolong
Package leaflet: Information for the user
Introduction
PACKAGE LEAFLET: INFORMATION FOR THE USER
Psicotric Prolong 300mg prolonged-release tablets EFG
quetiapine
Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you, because it may harm them.
- If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.
Leaflet contents:
- What Psicotric Prolong is and what it is used for
- What you need to know before taking Psicotric Prolong
- How to take Psicotric Prolong
- Possible side effects
- How to store Psicotric Prolong
- Contents of the pack and other information
1. What Psicotric Prolong is and what it is used for
Psicotric Prolong contains a substance called quetiapine. It belongs to a group of medicines known as antipsychotics. Psicotric Prolong can be used to treat several conditions, such as:
- Bipolar depression and major depressive episodes in major depressive disorder: where you feel sad. You may find that you feel depressed, guilty, lack energy, lose your appetite, or are unable to sleep.
- Mania: where you may feel highly excited, euphoric, agitated, enthusiastic, or hyperactive, or have poor judgment, which may include aggressive or violent behavior.
- Schizophrenia: where you may hear or feel things that are not there, believe things that are not true, or feel abnormally suspicious, anxious, confused, guilty, tense, or depressed.
When using Psicotric Prolong prolonged-release tablets to treat major depressive episodes in major depressive disorder, it will be taken in addition to another medicine you are already using for this condition.
Your doctor may continue prescribing Psicotric Prolong even after you start feeling better.
2. What you need to know before starting to take Psicotric Prolong
Do not take Psicotric Prolong:
- If you are allergic to quetiapine or to any of the other ingredients of this medicine (listed in section 6).
- If you are taking any of the following medicines:
- some medicines for HIV
- azole-type medicines (for fungal infections)
- erythromycin or clarithromycin (for infections)
- nefazodone (for depression).
Do not take Psicotric Prolong if any of the above applies to you. If you have any doubts, consult your doctor or pharmacist before taking Psicotric Prolong.
Warnings and precautions
Talk to your doctor or pharmacist before starting to take Psicotric Prolong if:
- You, or a family member, have or have had any heart problems, such as irregular heartbeat, weakening of the heart muscle, or inflammation of the heart, or if you are taking any medicine that may affect your heartbeat.
- You have low blood pressure.
- You have had a stroke, especially if you are elderly.
- You have liver problems.
- You have ever had a seizure (epileptic fit).
- You have diabetes or are at risk of developing diabetes. If so, your doctor may monitor your blood sugar levels while you are taking quetiapine.
- You know you have previously had low levels of white blood cells (which may or may not have been caused by other medicines).
- You are an elderly person with dementia (loss of brain functions). In this case, you should not take quetiapine, because the group of medicines to which Psicotric Prolong belongs may increase the risk of stroke, or in some cases the risk of death, in these individuals.
- You or a family member have a history of blood clots, as medicines like this have been associated with blood clot formation.
- You suffer from depression or other conditions treated with antidepressants.
Using these medicines together with Psicotric Prolong may cause serotonin syndrome, a potentially life-threatening condition (see “Other medicines and Psicotric Prolong”).
Contact your doctor immediately if, after taking Psicotric Prolong, you experience any of the following:
- A combination of fever, severe muscle stiffness, sweating, or decreased level of consciousness (a disorder known as “neuroleptic malignant syndrome”). Immediate medical treatment may be necessary.
- Uncontrolled movements, mainly of your face or tongue.
- Dizziness or feeling very sleepy. This may increase the risk of accidental injuries (falls) in elderly patients.
- Seizures (epileptic fits).
- A prolonged and painful erection (priapism).
- Fast or irregular heartbeats, even at rest, palpitations, breathing problems, chest pain, or unexplained tiredness. Your doctor should examine your heart and, if necessary, refer you immediately to a cardiologist.
These disorders may be caused by this type of medicine.
Inform your doctor as soon as possible if you have:
- Fever, flu-like symptoms, sore throat, or any other infection, as this could be due to a very low count of white blood cells and may require stopping treatment with quetiapine and/or additional treatment.
- Constipation along with persistent abdominal pain, or constipation that has not responded to treatment, as this could lead to a more serious intestinal blockage.
Suicidal thoughts and worsening of depression
If you are depressed, you may sometimes have thoughts of harming yourself or committing suicide. This risk may increase at the beginning of treatment, as all these medicines take time to work—usually about two weeks, but sometimes longer. These thoughts may also increase if you stop your medication abruptly. You may be more likely to have such thoughts if you are a young adult. Clinical trial data have shown an increased risk of suicidal thoughts and/or suicidal behavior in young adults under 25 years of age with depression.
If at any time you have thoughts of harming yourself or committing suicide, contact your doctor or go to a hospital immediately. It may help to tell a close friend or family member that you are depressed and ask them to read this leaflet. You may also ask them to let you know if they think your depression is getting worse or if they are concerned about changes in your behavior.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Psicotric Prolong must not be used in children and adolescents under 18 years of age.
Other medicines and Psicotric Prolong
Tell your doctor if you are taking, have recently taken, or might need to take any other medicine.
Do not take Psicotric Prolong if you are using any of the following medicines:
- Some medicines for HIV.
- Azole-type medicines (for fungal infections).
- Erythromycin or clarithromycin (for infections).
- Nefazodone (for depression).
Inform your doctor if you are using any of the following medicines:
- Medicines for epilepsy (such as phenytoin or carbamazepine).
- Medicines for high blood pressure.
- Barbiturates (for difficulty sleeping).
- Thioridazine or lithium (other antipsychotic medicines).
- Medicines that affect your heartbeat, for example, medicines that may cause an electrolyte imbalance (low levels of potassium or magnesium), such as diuretics (medicines to increase urination) or certain antibiotics (medicines to treat infections).
- Medicines that may cause constipation.
- Antidepressants. These medicines may interact with Psicotric Prolong and you may experience symptoms such as involuntary rhythmic muscle contractions, including muscles controlling eye movement, agitation, hallucinations, coma, excessive sweating, tremor, exaggerated reflexes, increased muscle tension, and body temperature above 38°C (serotonin syndrome). Contact your doctor if you experience these symptoms.
Before stopping any of your medicines, consult your doctor first.
Taking Psicotric Prolong with food, drinks, and alcohol
- Psicotric Prolong may be affected by food, and therefore you should take your tablets at least one hour before a meal or before bedtime.
- Be cautious about the amount of alcohol you consume. This is because the combined effect of Psicotric Prolong and alcohol may make you drowsy.
- Do not drink grapefruit juice while taking Psicotric Prolong. It may affect how the medicine works.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor before using this medicine. You should not take Psicotric Prolong during pregnancy unless you have discussed it with your doctor. You should not use Psicotric Prolong if you are breastfeeding.
The following symptoms, which may represent a withdrawal syndrome, may occur in newborns whose mothers have used quetiapine during the third trimester (last three months of pregnancy): tremor, muscle stiffness and/or weakness, drowsiness, agitation, breathing difficulties, and feeding problems. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and using machines
Quetiapine may cause symptoms such as drowsiness, dizziness, or vision disturbances, and may reduce reaction ability. These effects, as well as the illness itself, may impair your ability to drive or operate machinery. Therefore, do not drive, operate machinery, or engage in other activities requiring special attention until your doctor has assessed your response to this medicine.
Effect on Urine Drug Screening Tests
If you are undergoing a urine drug screening test, taking quetiapine may produce positive results for methadone or certain antidepressant medicines known as tricyclic antidepressants (TCAs) when certain analytical methods are used, even if you are not taking methadone or TCAs. If this occurs, a more specific test can be performed.
Psicotric Prolong contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; thus, it is essentially “sodium-free.”
3. How to take Psicotric Prolong
Follow exactly the administration instructions for this medicine as indicated by your doctor. If in doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your condition and individual needs but will usually be between 150 mg and 800 mg.
- You will take your tablets once daily.
- Do not split, chew, or crush the tablets.
- Swallow the tablets whole with water.
- Take the tablets without food (at least one hour before a meal or at bedtime; your doctor will tell you when).
- Do not drink grapefruit juice while taking Psicotric Prolong. It may affect how the medicine works.
- Do not stop taking your tablets even if you feel better, unless your doctor tells you to.
Liver problems
If you have liver problems, your doctor may adjust your dose.
Elderly patients
If you are elderly, your doctor may adjust your dose.
Use in children and adolescents
Psicotric Prolong must not be used in children and adolescents under 18 years of age.
If you take more Psicotric Prolong than you should
If you take more Psicotric Prolong than prescribed by your doctor, you may feel drowsy, dizzy, or experience abnormal heartbeats. Contact your doctor or nearest hospital immediately. Take the Psicotric Prolong tablets with you. You may also call the Toxicology Information Service at telephone number: 915620420, stating the name of the medicine and the amount taken.
If you forget to take Psicotric Prolong
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait and take the next dose at the usual time. Do not take a double dose to make up for the missed tablet.
If you stop taking Psicotric Prolong
If you stop taking Psicotric Prolong abruptly, you may have difficulty sleeping (insomnia), feel nauseous, or experience headache, diarrhea, vomiting, dizziness, or irritability. Your doctor may recommend gradually reducing the dose before stopping treatment.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine can cause adverse effects, although not everyone experiences them.
Very common adverse effects (may affect more than 1 in 10 people):
- Dizziness (which may lead to falls), headache, dry mouth.
- Drowsiness (which may diminish over time as you continue taking quetiapine), (which may lead to falls).
- Withdrawal symptoms (symptoms that occur when you stop taking quetiapine), including inability to sleep (insomnia), nausea, headache, diarrhoea, vomiting, dizziness, and irritability. Gradual discontinuation over a period of at least 1 to 2 weeks is recommended.
- Weight gain.
- Abnormal muscle movements. These include difficulty initiating muscle movements, tremor, restlessness, or painless muscle rigidity.
- Changes in levels of certain fats (triglycerides and total cholesterol).
Common adverse effects (may affect up to 1 in 10 people):
-
Fast heartbeat.
-
Feeling that your heart is pounding, racing, or beating irregularly.
-
Constipation, upset stomach (indigestion).
-
Feeling weak.
-
Swelling of arms or legs.
-
Low blood pressure when standing. This may make you feel dizzy or faint (which may lead to falls).
-
Increased blood sugar levels.
-
Blurred vision.
-
Abnormal dreams and nightmares.
-
Increased appetite.
-
Feeling irritable.
-
Speech and language disorders.
-
Suicidal thoughts and worsening of depression.
-
Shortness of breath.
-
Vomiting (mainly in elderly people).
-
Fever.
-
Changes in levels of thyroid hormones in blood.
-
Decrease in number of certain types of blood cells.
-
Increases in liver enzyme levels measured in blood.
-
Increases in prolactin hormone levels in blood. Elevated prolactin levels may, in rare cases, lead to the following:
o In both men and women: breast enlargement and unexpected milk production.
o In women: absence of menstrual periods or irregular periods.
Uncommon adverse effects (may affect up to 1 in 100 people):
- Epileptic seizures or convulsions.
- Allergic reactions which may include raised, itchy rashes (hives), skin swelling, and swelling around the mouth.
- Unpleasant sensations in the legs (also known as restless legs syndrome).
- Difficulty swallowing.
- Involuntary movements, mainly of the face or tongue.
- Sexual dysfunction.
- Diabetes.
- Changes in the heart's electrical activity seen on ECG (prolongation of the QT interval).
- Slower than normal heart rate, which may occur at the beginning of treatment and may be associated with low blood pressure and fainting.
- Difficulty urinating.
- Fainting (which may lead to falls).
- Stuffy nose.
- Decrease in red blood cell count.
- Decrease in sodium levels in blood.
- Confusion.
Rare adverse effects (may affect up to 1 in 1,000 people):
- A combination of high temperature (fever), sweating, muscle stiffness, and extreme drowsiness or dizziness (a disorder known as "neuroleptic malignant syndrome").
- Yellowing of the skin and eyes (jaundice).
- Liver inflammation (hepatitis).
- Prolonged and painful erection (priapism).
- Breast enlargement and unexpected milk production (galactorrhoea).
- Menstrual disorders.
- Blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty breathing. If you notice any of these symptoms, seek immediate medical help.
- Walking, talking, eating, or other activities while asleep.
- Decreased body temperature (hypothermia).
- Inflammation of the pancreas.
- A condition (called "metabolic syndrome") in which you may experience a combination of 3 or more of the following: increased abdominal fat, decreased "good cholesterol" (HDL-C), increased blood triglycerides, increased blood pressure, and increased blood sugar.
- A combination of fever, flu-like symptoms, sore throat, or any other infection with a very low white blood cell count, a condition known as agranulocytosis.
- Intestinal obstruction.
- Increased blood creatine phosphokinase (a substance from muscles).
Very rare adverse effects (may affect up to 1 in 10,000 people):
- Severe rash, blisters, or red spots on the skin.
- Severe allergic reaction (called anaphylaxis) which may cause difficulty breathing or shock.
- Rapid swelling of the skin, usually around the eyes, lips, and throat (angioedema).
- A serious condition with blisters on the skin, mouth, eyes, and genitals (Stevens-Johnson syndrome).
- Inappropriate secretion of a hormone that controls urine volume.
- Rupture of muscle fibres and muscle pain (rhabdomyolysis).
- Worsening of pre-existing diabetes.
Not known (frequency cannot be estimated from available data):
- Skin rashes with irregular red patches (erythema multiforme).
- Sudden and severe allergic reaction with symptoms such as fever, skin blisters, and skin peeling (toxic epidermal necrolysis).
- Withdrawal symptoms may occur in newborns of mothers who used quetiapine during pregnancy.
- Drug rash with eosinophilia and systemic symptoms (DRESS). Widespread rash, high body temperature, elevated liver enzymes, blood abnormalities (eosinophilia), enlarged lymph nodes, and involvement of other organs (drug rash with eosinophilia and systemic symptoms, also known as DRESS). If you develop these symptoms, stop taking quetiapine and contact your doctor or seek immediate medical attention.
- Heart muscle disorder (cardiomyopathy).
- Inflammation of the heart muscle (myocarditis).
- Inflammation of blood vessels (vasculitis), often with a skin rash consisting of small red or purple spots.
The class of medicines to which Quetiapina Qualigen belongs may cause heart rhythm problems that can be serious and, in severe cases, may be fatal.
Some adverse effects are only detected through blood tests. These include changes in levels of certain fats (triglycerides and total cholesterol) or blood sugar, changes in thyroid hormone levels in blood, increased liver enzymes, decreased numbers of certain blood cells, decreased red blood cell count, increased blood creatine phosphokinase (a substance found in muscles), decreased sodium levels in blood, and increased prolactin hormone levels in blood. Elevated prolactin levels may, in rare cases, lead to the following:
- In both men and women: breast enlargement and unexpected milk production.
- In women: absence of menstrual periods or irregular periods.
Your doctor may ask you to have blood tests from time to time.
Adverse effects in children and adolescents
The same adverse effects that may occur in adults may also occur in children and adolescents.
The following adverse effects have been observed more frequently in children and adolescents, or were not observed in adults:
Very common adverse effects (may affect more than 1 in 10 people):
- Increased levels of a hormone called prolactin in blood. Elevated prolactin levels may, in rare cases, lead to the following:
- In both boys and girls: breast enlargement and unexpected milk production.
- In girls: absence of menstrual periods or irregular periods.
- Increased appetite.
- Vomiting.
- Abnormal muscle movements. These include difficulty initiating muscle movements, tremors, restlessness, or painless muscle rigidity.
- Increased blood pressure.
Common adverse effects (may affect up to 1 in 10 people):
- Feeling weak, fainting (which may lead to falls).
- Stuffy nose.
- Feeling irritable.
Reporting of adverse effects
If you experience any adverse effect, talk to your doctor, pharmacist, or nurse, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Conservation of Psicotric Prolong
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month indicated.
This medicine does not require any special storage temperature. Store in the original packaging to protect from moisture. Medicines should not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE Point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of unused medicines and their containers. This will help protect the environment.
6. Contents of the pack and other information
Composition of Psicotric Prolong
The active substance is quetiapine. The tablets contain 300 mg of quetiapine (as quetiapine fumarate).
The other components are:
Tablet core: hypromellose, microcrystalline cellulose, anhydrous sodium citrate, magnesium stearate
Tablet coating: hypromellose, titanium dioxide (E-171), macrogol 400, polysorbate 80, yellow iron oxide (E-172), red iron oxide (E-172), black iron oxide (E-172).
Appearance of the product and contents of the pack
The tablets are light yellow in color and are marked with "Q 300" on one side.
Available pack sizes are:
Presented in PVC/PVDC – aluminum blisters, in packs of 10, 30, 50, 60 and 100 tablets.
Presented in white opaque high-density polyethylene bottles with white opaque polypropylene caps and desiccant, in packs of 60 tablets.
Only certain pack sizes may be commercially available.
Marketing Authorization Holder
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona - Spain
Manufacturer
Merckle GmbH
Ludwig-Merckle Strasse 3
D-89143 Blaubeuren-Weiler
Germany
Teva UK
Brampton Road, Hampden Park, Eastbourne, East Sussex, BN22 9AG
United Kingdom
Date of latest revision of this leaflet: January 2026
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/